Adamax Protocol
Dosing & Research
Last Updated: September 4, 2026
Attention/focus models, BDNF and neuroplasticity research, Neuroprotection, Nasal nootropic delivery studies
Half-Life
Not Well Characterized
Administration
Subcutaneous
Frequency
1x Daily
How It Works
- Attention/focus models
- BDNF and neuroplasticity research
- Neuroprotection
- Nasal nootropic delivery studies
Dosing Structure
Dose
200–300 mcg
Frequency
1x Daily
Notes
Inject: Belly, thigh, upper arm. Morning preferred. Break: 2-4 weeks to allow receptor recovery period.
Example Protocols
Dose: 200–300 mcg
Frequency: 1x Daily
Duration: 2-4 weeks
Off Period: Not listed
Find Research Grade Adamax
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Inject: Belly, thigh, upper arm.
•
Morning preferred.
•
Break: 2-4 weeks to allow receptor recovery period.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.